Promis Neurosciences Inc. · NASDAQ:PMN
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. reported a 9.99% stake in Promis Neurosciences Inc. (Schedule 13G)
Event Mar 11, 2026 · Filed Mar 18, 2026
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. reported a 9.99% stake in Promis Neurosciences Inc., 895,877 shares, as a passive investor on Mar 11, 2026. Filed Mar 18, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 895,877
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 9.99% | 895,877 |
Source
Related
- Promis Neurosciences Inc.
- Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.
- Promis Neurosciences Inc. shareholders
- Schedule 13G/A · Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. · Aug 13, 2026
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Kaplan Johanne · Aug 7, 2026
- Schedule 13G · Wellington Management Group LLP · May 15, 2026
- Schedule 13G · Great Point Partners LLC · May 15, 2026